Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

6-factor prognostic model for patients with advanced urothelial carcinoma

Dr Gregory Pond - McMaster University, Hamilton, Ontario

9 Feb 2018

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

9 Feb 2018

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK

9 Feb 2018

Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy

Dr David Miyamoto - Massachusetts General Hospital, Boston, USA

9 Feb 2018

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA

$Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )$

9 Feb 2018

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium

9 Feb 2018

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

Dr Ricardo Leão - University of Toronto, Toronto, Canada

8 Feb 2018

Radium-223 for bone predominant metastatic castration resistant prostate cancer

Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA

8 Feb 2018

FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer

Dr Eugene Teoh - University of Oxford, Oxford, UK

8 Feb 2018

PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial

Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA

8 Feb 2018

POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance in upper tract urothelial cancer

Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK

8 Feb 2018

Latest in adjuvant therapy for renal cell carcinoma

Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA

8 Feb 2018

Video

More from ecancer